4mo
Share
3mo
I generally offer Rx weight loss medications to all my pts who are qualified, many pts are reluctant and afraid of the side effects, most pts believe they can lose weight themself, coverage is still a major issue in my area.
Share
4mo
Sarcopenic obesity: a review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40215288/
The global increase in life expectancy has led to a concomitant rise in diagnoses of sarcopenia. At the same time, the epidemic levels of obesity have given rise to the...
Sarcopenic obesity, combining muscle loss and obesity, is rising globally. It affects not only older adults but also individuals with chronic disease or rapid weight loss, remaining underdiagnosed and undertreated.
Share
4mo
A landmark study in Lancet Diabetes & Endocrinology identified a T1D subtype in Sub-Saharan African youth and Black Americans lacking islet autoantibodies. This insulin-deficient form isn't autoimmune, urging revised diagnostic, prevention, and treatment strategies.
Share
4mo
Did you know? A randomized crossover trial published in August 2025 demonstrated that a DASH diet modified for type 2 diabetes (DASH4D) significantly improved glycemic control. Adults with T2D on the DASH4D regimen experienced greater reductions in mean CGM glucose and increased time in the target range compared to standard U.S. dietary patterns. Improvements were most pronounced in participants with elevated baseline A1C.
Could evidence-based dietary frameworks like DASH4D enhance existing treatment plans for patients with complex metabolic profiles?
Could evidence-based dietary frameworks like DASH4D enhance existing treatment plans for patients with complex metabolic profiles?
Share